{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06005428",
            "orgStudyIdInfo": {
                "id": "CRD-4730-201"
            },
            "organization": {
                "fullName": "Cardurion Pharmaceuticals, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)",
            "officialTitle": "A Phase 2A, Investigator & Subject Blinded, Sponsor Unblinded, Placebo-Controlled, Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia",
            "acronym": "CPVT",
            "therapeuticArea": [
                "Critical Care",
                "Cardiovascular",
                "Other"
            ],
            "study": "effectiveness-of-crd-in-participants-with-catecholaminergic-polymorphic-ventricular-tachycardia-cpvt"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11-29",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-08-08",
            "studyFirstSubmitQcDate": "2023-08-17",
            "studyFirstPostDateStruct": {
                "date": "2023-08-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Cardurion Pharmaceuticals, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 2, multicenter, double-blind, sponsor unblinded, placebo-controlled, single-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 when administered as single oral doses to participants with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). The study will have 2 cohorts in which participants with CPVT will participate in a 3-period, randomized 2-sequence study. Each participant will receive 2 different doses of CRD-4730 and 1 dose of matching placebo, with each study drug administered as a single dose."
        },
        "conditionsModule": {
            "conditions": [
                "CPVT1",
                "Heart Defects, Congenital",
                "Heart Diseases",
                "Ventricular Tachycardia"
            ],
            "keywords": [
                "CaMKII",
                "Catecholaminergic polymorphic VT",
                "Ventricular Tachycardia",
                "CRD-4730"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "3-period randomized 2-sequence study",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "maskingDescription": "Investigator and Subject Blinded, Sponsor Unblinded; Placebo-controlled",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose 1",
                    "type": "EXPERIMENTAL",
                    "description": "CRD-4730 Dose 1 capsule",
                    "interventionNames": [
                        "Drug: CRD-4730"
                    ]
                },
                {
                    "label": "Dose 2",
                    "type": "EXPERIMENTAL",
                    "description": "CRD-4730 Dose 2 capsule",
                    "interventionNames": [
                        "Drug: CRD-4730"
                    ]
                },
                {
                    "label": "Dose 3",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo capsule to match CRD-4730",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "CRD-4730",
                    "description": "Oral CRD-4730 in capsule form",
                    "armGroupLabels": [
                        "Dose 1",
                        "Dose 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo to match CRD-4730 in capsule form",
                    "armGroupLabels": [
                        "Dose 3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Treatment Emergent Adverse Events (TEAEs)",
                    "description": "The number of participants with TEAEs including drug-related AEs, serious AEs (SAEs), and AEs leading to study drug discontinuation will be assessed.",
                    "timeFrame": "Baseline to Day 22"
                },
                {
                    "measure": "Changes in Laboratory Assessments",
                    "description": "The number of participants who have normal/ abnormal values at Baseline compared to normal/ abnormal values post-Baseline will be assessed for hematology, serum chemistry and urinalysis.",
                    "timeFrame": "Baseline to Day 15"
                },
                {
                    "measure": "Changes in Vital Signs Measurement: Systolic and Diastolic blood pressure",
                    "description": "Percent change from Baseline to post Baseline will be assessed for systolic and diastolic blood pressure",
                    "timeFrame": "Baseline to Day 15"
                },
                {
                    "measure": "Changes in Vital Signs Measurement: Pulse Rate",
                    "description": "Percent change from Baseline to post Baseline will be assessed for pulse rate",
                    "timeFrame": "Baseline to Day 15"
                },
                {
                    "measure": "Changes in Vital Signs Measurement: Respiratory Rate",
                    "description": "Percent change from Baseline to post Baseline will be assessed for respiratory rate",
                    "timeFrame": "Baseline to Day 15"
                },
                {
                    "measure": "Changes in Vital Signs Measurement: Body Temperature",
                    "description": "Percent change from Baseline to post Baseline will be assessed for body temperature",
                    "timeFrame": "Baseline to Day 15"
                },
                {
                    "measure": "Changes in Physical Exam",
                    "description": "General physical exams will be carried out to detect any abnormalities in the cardiovascular, respiratory and other body systems",
                    "timeFrame": "Baseline to Day 22"
                },
                {
                    "measure": "Changes in Electrocardiogram (ECG) Measurements",
                    "description": "Number of participants who have normal/abnormal ECG measurements at Baseline will be compared to normal/abnormal ECG measurement post Baseline",
                    "timeFrame": "Baseline to Day 22"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Ventricular Arrhythmia (VA) score during Exercise Stress Test (EST)",
                    "description": "The VA score is a physician administered score on a scale of 0-5 with higher numbers being worse.",
                    "timeFrame": "Baseline to Day 1"
                },
                {
                    "measure": "Change in Ventricular Arrhythmia (VA) score during Exercise Stress Test (EST)",
                    "description": "The VA score is a physician administered score on a scale of 0-5 with higher numbers being worse.",
                    "timeFrame": "Baseline to Day 8"
                },
                {
                    "measure": "Change in Ventricular Arrhythmia (VA) score during Exercise Stress Test (EST)",
                    "description": "The VA score is a physician administered score on a scale of 0-5 with higher numbers being worse.",
                    "timeFrame": "Baseline to Day 15"
                },
                {
                    "measure": "Assessment of PK effect",
                    "description": "Plasma concentrations of CRD-4730 over time for each treatment period",
                    "timeFrame": "Baseline through Day 15"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Males or Females \u226518 years of age, at screening.\n2. Confirmed CPVT diagnosis, based on genetic screening for a known RyR2 mutation and a clinical phenotype consistent with CPVT at screening.\n3. Ability to perform an Exercise Stress Test (EST) during which exercise-induced ventricular couplets or higher-grade VA (equivalent to a VA score \u22653) are identified by the investigator.\n4. Stable doses of any anti-arrhythmic medication, except amiodarone, for 4 weeks prior to screening.\n5. Adhere to all contraceptive criteria.\n\nExclusion Criteria:\n\n1. Clinically significant structural heart disease, diagnosis of heart failure, or clinically significant coronary artery disease.\n2. History of a myocardial infarction, cerebrovascular accident, or transient ischemic attack within 3 months of screening.\n3. History of malignancy within the past 5 years at screening (except successfully treated basal cell carcinoma or non-metastatic squamous cell carcinoma of the skin or cervical carcinoma in situ).\n4. Female participant that is pregnant or lactating/ breastfeeding, or has plans to do so during the study or within 3 months following last dose of study drug.\n5. Use of amiodarone with 3 months prior to screening. NOTE: other protocol defined Inclusion/ Exclusion criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jason Homsy, M.D., Ph.D.",
                    "role": "CONTACT",
                    "phone": "(617) 863-8088",
                    "email": "jason.homsy@cardurion.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jason Homsy, M.D., Ph.D.",
                    "affiliation": "Executive Medical Director",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cincinnati Children's Hospital Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Richard Czosek, MD",
                            "role": "CONTACT",
                            "phone": "513-636-2237",
                            "email": "richard.czosek@cchmc.org"
                        },
                        {
                            "name": "Richard Czosek, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Wilson Lam, MD",
                            "role": "CONTACT",
                            "phone": "832-826-2899",
                            "email": "wlam@bcm.edu"
                        },
                        {
                            "name": "Wilson Lam, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Edmonton",
                    "state": "Alberta",
                    "zip": "T6G 2R7",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 53.55014,
                        "lon": -113.46871
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Vancouver",
                    "state": "British Columbia",
                    "zip": "V6H 3N1",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 49.24966,
                        "lon": -123.11934
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Vancouver",
                    "state": "British Columbia",
                    "zip": "V6Z1Y6",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Andrew Krahn, MD",
                            "role": "CONTACT",
                            "phone": "(604) 875-5069",
                            "email": "akrahn@mail.ubc.ca"
                        },
                        {
                            "name": "Andrew Krahn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 49.24966,
                        "lon": -123.11934
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "RECRUITING",
                    "city": "London",
                    "state": "Ontario",
                    "zip": "N6A 5A5",
                    "country": "Canada",
                    "contacts": [
                        {
                            "name": "Habib Khan, MD",
                            "role": "CONTACT",
                            "phone": "519-663-3746",
                            "email": "habib.khan@lhsc.on.ca"
                        },
                        {
                            "name": "Habib Khan, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.98339,
                        "lon": -81.23304
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Nantes",
                    "state": "Loire-Atlantique",
                    "zip": "44805",
                    "country": "France",
                    "geoPoint": {
                        "lat": 47.21725,
                        "lon": -1.55336
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "RECRUITING",
                    "city": "Bron",
                    "zip": "69677",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Philippe Chevalier, MD",
                            "role": "CONTACT",
                            "phone": "+33472357027",
                            "email": "philippe.chevalier@chu-lyon.fr"
                        },
                        {
                            "name": "Philippe Chevalier, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.73333,
                        "lon": 4.91667
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "RECRUITING",
                    "city": "Paris",
                    "zip": "75018",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Isabelle Denjoy, MD",
                            "role": "CONTACT",
                            "phone": "+33140032189",
                            "email": "isabelle.denjoy@aphp.fr"
                        },
                        {
                            "name": "Isabelle Denjoy, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.85341,
                        "lon": 2.3488
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "RECRUITING",
                    "city": "Saint-Herblain",
                    "zip": "44800",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Vincent Probst, MD",
                            "role": "CONTACT",
                            "phone": "33 2 40 16 59 93",
                            "email": "vincent.probst@chu-nantes.fr"
                        },
                        {
                            "name": "Vincent Probst, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.21765,
                        "lon": -1.64841
                    }
                },
                {
                    "facility": "Cardurion Investigative Site",
                    "status": "RECRUITING",
                    "city": "Pavia",
                    "state": "Lombardia",
                    "zip": "27100",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Silvia Priori, MD",
                            "role": "CONTACT",
                            "phone": "390382592774",
                            "email": "silvia.priori@icsmaugeri.it"
                        },
                        {
                            "name": "Silvia Priori, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.19205,
                        "lon": 9.15917
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000013610",
                    "term": "Tachycardia"
                },
                {
                    "id": "D000017180",
                    "term": "Tachycardia, Ventricular"
                },
                {
                    "id": "D000006330",
                    "term": "Heart Defects, Congenital"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000001145",
                    "term": "Arrhythmias, Cardiac"
                },
                {
                    "id": "D000075224",
                    "term": "Cardiac Conduction System Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000018376",
                    "term": "Cardiovascular Abnormalities"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "asFound": "Heart Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16384",
                    "name": "Tachycardia",
                    "asFound": "Tachycardia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9418",
                    "name": "Heart Defects, Congenital",
                    "asFound": "Heart Defects, Congenital",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19488",
                    "name": "Tachycardia, Ventricular",
                    "asFound": "Ventricular Tachycardia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "asFound": "Defects, Congenital",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M1472",
                    "name": "Cardiac Conduction System Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M20503",
                    "name": "Cardiovascular Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "T1013",
                    "name": "Catecholaminergic Polymorphic Ventricular Tachycardia",
                    "asFound": "Catecholaminergic Polymorphic Ventricular Tachycardia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}